Click for full image >>

TG Therapeutics

is a biopharmaceutical company focused on the development of
novel treatments for B-cell malignancies and autoimmune diseases.

 

 

For Investors

NASDAQ: TGTX
Stock Quote at: May 2, 4:00PM EDT

Last: $9.28

Change: $0.17 (1.87%)

Quotes provided by Google - Min 15 minute delay